熱門資訊> 正文
Grifols考虑部分美国生物制药业务IPO
2026-03-25 05:40
- Spanish pharma Grifols, S.A. (GRFS) said that its board has decided to evaluate a potential US IPO of its shares of its US biopharma business.
- The company said it was making the move as part of its "self-sufficiency program."
- Grifols noted there is no guarantee an IPO will go through and would need to go through regulatory and legal requirements, internal approvals, and favorable market conditions.
More on Grifols, S.A.
- Grifols: I'm Very Happy To Add In 2026
- Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript
- Grifols, S.A. 2025 Q4 - Results - Earnings Call Presentation
- Historical earnings data for Grifols, S.A.
- Dividend scorecard for Grifols, S.A.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
